We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Innovation in Cancer, Infectious Disease Research

News   Jan 20, 2017 | Original story from UC Berkeley

 
Innovation in Cancer, Infectious Disease Research

Stephen Isaacs, CEO of Aduro Biotech, at the launch of the IVRI on March 23. (Peg Skorpinski photos)

 
 
Advertisement
 

RELATED ARTICLES

Human Cells Can Convert RNA Sequences Into DNA

News

Researchers have provided evidence that RNA segments can be written back into DNA, which potentially challenges the central dogma in biology and could have wide implications in biology.

READ MORE

Ovarian Cancer Treatment Proves Effective in Preclinical Model

News

Preclinical trials of Pb-214-labeled Trastuzumab, a new ovarian cancer treatment, have produced successful results, dramatically limiting tumor growth and decreasing tumor mass.

READ MORE

Omega-3 Fatty Acid Kills Tumor Cells in Culture

News

Docosahexaenoic acid (DHA) is an Omega-3 fatty acid that is associated with a reduction in the incidence of cancer. Researchers have discovered the biochemical mechanism that allows DHA to slow tumor development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE